NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS CEANOTHUS AMERICANUS SICCUM FOR HOMOEOPATHIC PREPARATIONS

Similar documents
OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS

COMMON BARBERRY FOR HOMOEOPATHIC PREPARATIONS BERBERIS VULGARIS FOR HOMOEOPATHIC PREPARATIONS

ARNICA (WHOLE PLANT) FOR HOMOEOPATHIC PREPARATIONS ARNICA MONTANA FOR HOMOEOPATHIC PREPARATIONS

COCHINEAL FOR HOMOEOPATHIC PREPARATIONS COCCUS CACTI FOR HOMOEOPATHIC PREPARATIONS

AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

LAVENDER FOR HOMOEOPATHIC PREPARATIONS LAVANDULA VERA FOR HOMOEOPATHIC PREPARATIONS

THIN LAYER CHROMATOGRAPHY

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

Guide. homoeopathic preparations. for the elaboration of monographs on

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Title Revision n date

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

Lutein Esters from Tagetes Erecta

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

THERMALLY OXIDIZED SOYA BEAN OIL

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

Draft proposal for The International Pharmacopoeia

19 Nosiheptide S O. For chickens (excluding broilers) For broilers. Finishing period broilers Growing period broilers. Stating chicks Growing chicks

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

What you should bring during the Pharmacognosy Laboratory I - White coat - Cleaning tissues - Matches - The printouts for these presentations -

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

Heparin Sodium ヘパリンナトリウム

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

EMTRICITABINE AND TENOFOVIR TABLETS

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

TENOFOVIRI DISOPROXILIS FUMARAS TENOFOVIR DISOPROXIL FUMARATE

E17 ETHYLCELLULOSE. Revision 3 Stage 4

The International Pharmacopoeia TENOFOVIR DISOPROXIL FUMARATE (JULY 2012)

EXPERIMENT 13: Isolation and Characterization of Erythrocyte

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

Pharmacognostical and Phytochemical Studies on Spondia pinnata Leaf Mathew George* and Lincy Joseph

Research Article GALLIC ACID AND FLAVONOID ACTIVITIES OF AMARANTHUS GANGETICUS

ISOMALT. Stage 4. C 12 H 24 O 11 M r C 12 H 24 O 11, 2H 2 O M r DEFINITION

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

TLC SEPARATION OF AMINO ACIDS

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

Purity Tests for Modified Starches

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

DRAFT TANZANIA STANDARD

PROPOSAL FOR REVISION OF MONOGRAPH IN THE FOURTH EDITION OF The International Pharmacopoeia MEFLOQUINE HYDROCHLORIDE (JANUARY 2012) DRAFT FOR COMMENT

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Jagua (Genipin-Glycine) Blue (Tentative)

Determination of Tanninoids. Analytical Pharmacognosy

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

ISSN Volume 2 (2015) The 3rd International Conference on Biological Science 2013 (The 3rd ICBS-2013)

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

PHCH 402: Analytical Quality Control Different methods of analysis of some groups of drugs in common use in Nigeria (8 hrs)

BRIEFING Assay + + +

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

Phrmacognostical & Pharmaceutical study

Amendment of Standards for Specification, Scope, Application and Limitation of Food Additives

10 Sulfaquinoxaline H N O S O. 4-amino-N-quinoxalin-2-ylbenzenesulfonamide C 14 H 12 N 4 O 2 S MW: CAS No.:

2 Avilamycin R 1. For chickens (except for broilers) Starting chicks Growing chicks. Starting broilers. Finishing broilers

EXPERIMENT 4 DETERMINATION OF REDUCING SUGARS, TOTAL REDUCING SUGARS, SUCROSE AND STARCH

STABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.

Use of degradable cationic surfactants with cleavable linkages for enhancing the. chemiluminescence of acridinium ester labels. Supplementary Material

Application Note Soy for Isoflavones by HPLC. Botanical Name: Glycine max L. Common Names: Parts of Plant Used: Beans.

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

Dhanashri Mestry, Vidya V. Dighe

Petrolatum. Stage 4, Revision 1. Petrolatum is a purified semi solid mixture of hydrocarbons obtained from petroleum.

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

Supporting Information for. Boronic Acid Functionalized Aza-Bodipy (azabdpba) based Fluorescence Optodes for the. analysis of Glucose in Whole Blood

ph Switchable and Fluorescent Ratiometric Squarylium Indocyanine Dyes as Extremely Alkaline Sensors

Chakraborthy et al., IJPSR, 2010; Vol. 1(9):76-80 ISSN: PHARMACOGNOSTIC STUDIES OF NERIUM INDICUM. A. Shah and G. S. Chakraborthy* ABSTRACT

COUMARINS, LIGNANS, DIARYLHEPTANOIDS

DRAFT EAST AFRICAN STANDARD

FLUNITRAZEPAM Latest Revision: January 24, 2006

Optimization of Enzyme-assisted Ultrasonic Extraction of Total Ginsenosides from Ginseng Roots Guangna LIU, Yulin ZUO, Jing ZHANG

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

STANDARD OPERATING PROTOCOL (SOP)

Most of the ethanol that is used as a biofuel in this country is produced from corn.

HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

MONOGRAPHS (USP) Saccharin Sodium

E55A GELATIN, GELLING GRADE Gelatina

Available online at Universal Research Publications. All rights reserved. Original Article

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

BRIEFING. 1. Definition Changed to include only Wheat Starch, as to conform to the individual monograph for Wheat Starch.

28 Lasalocid sodium OH O. Lasalocid C 34 H 54 O 8 MW: CAS No.:

Transcription:

NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS CEANOTHUS AMERICANUS SICCUM FOR HOMOEOPATHIC PREPARATIONS Ceanothus americanus siccum ad praeparationes homoeopathicas Other Latin name used in homoeopathy : Ceanothus DEFINITION Dried leaves of Ceanothus americanus L. Content : minimum 2.3 per cent of total flavonoids, expressed as rutin (C 27 H 30 O 16,3H 2 O; M r 665). IDENTIFICATION A. Simple, entire leaf, oval to oblong-oval, borne on a short petiole, sometimes curved or rolled on itself, 3-9 cm long and 1-3 cm large. Cordiform base or slightly rounded ; obtuse apex, acute or acuminate. The margins of the lamina are slightly dentate. Glossy, green upper side of the leaf, underside pubescent near the veins. Three veins emerge from the petiole to become almost parallel ; secondary veins emerge from the central vein in the upper half of the leaf and terminate at the apex, both lateral veins terminate in the upper three-quarters of the lamina. B. Reduce New Jersey tea, dried to a powder (355). The powder is yellowishbrown. Examine under a microscope, using chloral hydrate solution R. The powder contains the following elements : numerous fragments of lamina ; between the veins upper epidermis consisting of polyhedral cells and rounded cells of palisade parenchyma ; lower epidermis with polyhedral cells showing numerous anomocytic stomata (2.8.3) ; at the level of the veins epidermises with rectangular cells bearing uni or multicellular covering trichomes with thick, sclerified, canaliculate base, and tapered tip ; spiraled or annular xylem vessels ; calcium oxalate closters. C. Thin-layer chromatography (2.2.27). Test solution. Add 30 ml of ethanol (65 per cent V/V) R to 3 g of finelycut drug. Cover. Heat on a water-bath at 60 o C for 15 min. Allow to cool. Filter. 2002-2008.

2 NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS Reference solution. Dissolve 10 mg of quercitrin R and 10 mg of rutin R in 10 ml methanol R. Plate : TLC silica gel plate R. Mobile phase : anhydrous formic acid R, water R, ethyl acetate R (10 :10 :80 V/V/V). Application : 20 ml, as bands. Development : over a path of 10 cm. Drying : in air. Detection : first spray with a 10 g/l solution of diphenylboric acid aminoethyl ester R in methanol R then with a 50 g/l solution of macrogol 400 R in methanol R. Allow the plate to dry in air for about 30 min. Examine in ultraviolet light at 365 nm. Results : see below the sequence of fluorescent zones present in the reference solution and test solution chromatograms. Furthermore other faint, fluorescent zones may be present in the chromatogram obtained with the test solution. Top of the plate A greenish-yellow zone Quercitrin : an orange zone A green zone more or less merged with a yellow zone above One-two more or less merged yellow zones Rutin : an orange zone A yellow zone Reference solution Test solution TESTS Foreign matter (2.8.2) : maximum 5 per cent. Loss on drying (2.2.32) : maximum 12.0 per cent, determined on 1.0 g of powdered drug (355), by drying in an oven at 100-105 o C for 2 h. Total ash (2.4.16) : maximum 7.0 per cent, determined on 1.0 g of powdered drug (355).

NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS 3 ASSAY Ultraviolet and visible absorption spectrophotometry (2.2.25). Stock solution. In a 100 ml flask, place 1.000 g of powered drug (355). Add 40 ml of ethanol (60 per cent V/V) R and heat under a reflux condenser on a water-bath at 80 o C for 1 h. Allow to decant and filter the supernatant liquid. Dissolve the residue in 40 ml of ethanol (60 per cent V/V) R. Heat again under a reflux condenser on a water-bath at 80 o C for 1 h. Filter. Rinse the flask and the filter with ethanol (60 per cent V/V) R. Ina 100.0 ml volumetric flask mix the supernatant liquid and the washings and dilute to 100.0 ml with ethanol (60 per cent V/V) R. Evaporate 5.0 ml of this solution to dryness under reduced pressure. Dilute the residue in 25.0 ml of a acid R. Test solution. To 10.0 ml of stock solution, add 10.0 ml of a solution of 25.0 g/l of boric acid R and 20.0 g/l of oxalic acid Rinanhydrous formic acid R then dilute to 25.0 ml with glacial acetic acid R. Compensation liquid. To 10.0 ml of stock solution, add 10.0 ml of anhydrous formic acid R and dilute to 25.0 ml with glacial acetic acid R. Reference stock solution. Dissolve 10.0 mg of rutin CRS in a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R and dilute to 50.0 ml with the same mixture. To 10 ml of this solution add a acid R and dilute to 25.0 ml with the same mixture. Reference solution. To 5.0 ml of reference stock solution, add 5.0 ml of a acid R and 10.0 ml of a solution of 25.0 g/l of boric acid R and 20.0 g/l of oxalic acid Rinanhydrous formic acid R then dilute to 25.0 ml with glacial acetic acid R. Reference compensation liquid. To 5.0 ml of reference stock solution, add 5.0 ml of a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R. Then add 10.0 ml of anhydrous formic acid R and dilute to 25.0 ml with glacial acetic acid R. Thirty min after the addition of the last reagent, measure the absorbance of the test solution and of the reference solution at 420 nm, in comparison with the compensation liquids. Calculate the percentage content of total flavonoids, expressed as rutin, from the expression : 2002-2008.

4 NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS A 1 m 2 2 p A 2 m 1 A 1 = absorbance of the test solution, A 2 = absorbance of the reference solution, m 1 = mass of the drug sample in the stock solution, in grams, m 2 = mass of rutin sample in the reference stock solution, in grams, p = percentage content of rutin in rutin CRS. STOCK DESCRIPTION New Jersey tea, dried mother tincture is prepared with ethanol (65 per cent V/V), using the dried leaf of Ceanothus americanus L. Content : minimum 0.20 per cent m/m of total flavonoids, expressed as rutin (C 27 H 30 O 16,3H 2 O; M r 665). PRODUCTION Method 4c (2371). Fragmented drug. Maceration time : about 3 weeks. CHARACTERS Brown liquid. IDENTIFICATION Thin-layer chromatography (2.2.27). Test solution. Mother tincture. Reference solution. Dissolve 10 mg of quercitrin R and 10 mg of rutin R in 10 ml of methanol R. Plate : TLC silica gel plate R. Mobile phase : anhydrous formic acid R, water R, ethyl acetate R (10 :10 :80 V/V/V).

NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS 5 Application : 20 ml, as bands. Development : over a path of 10 cm. Drying : in air. Detection : first spray with a 10 g/l solution of diphenylboric acid aminoethyl ester R in methanol R then with a 50 g/l solution of macrogol 400 R in methanol R. Allow the plate to dry in air for about 30 min. Examine in ultraviolet light at 365 nm. Results : see below the sequence of fluorescent zones in the reference solution and the test solution chromatograms. Furthermore other faint, fluorescent zones may be present in the chromatogram obtained with the test solution. Top of the plate A greenish-yellow zone Quercitrin : an orange zone A green zone more or less merged, topped by a yellow zone One-two more or less merged yellow zones Rutin : an orange zone A yellow zone Reference solution Test solution TESTS Ethanol content (2.9.10) : 60 per cent V/V to 70 per cent V/V. Dry residue (2.8.16) : minimum 1.2 per cent m/m. ASSAY Ultraviolet and visible absorption spectrophotometry (2.2.25). Stock solution. Evaporate 1.000 g of mother tincture to dryness under reduced pressure. Dilute the residue in 25.0 ml of a mixture of 10 volumes of methanol R and 100 volumes of glacial formic acid R. Test solution. To 5.0 ml of stock solution, add 5.0 ml of a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R then 10.0 ml of a solution of 25.0 g/l of boric acid R and 20.0 g/l of oxalic acid R in anhydrous formic acid R and dilute to 25.0 ml with glacial acetic acid R. 2002-2008.

6 NEW JERSEY TEA, DRIED FOR HOMOEOPATHIC PREPARATIONS Compensation liquid. To 5.0 ml of stock solution, add 5.0 ml of a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R then 10.0 ml of anhydrous formic acid R and dilute to 25.0 ml with glacial acetic acid R. Reference stock solution. Dissolve 10.0 mg of rutin CRS in a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R and dilute to 50.0 ml with the same mixture. To 10.0 ml of this solution, add a acid R and dilute to 25.0 ml with the same mixture. Reference solution. To 5.0 ml of reference stock solution, add 5.0 ml of a acid R then 10.0 ml of a solution of 25.0 g/l of boric acid R and 20.0 g/l of oxalic acid R in anhydrous formic acid R and dilute to 25.0 ml with glacial acetic acid R. Reference compensation liquid. To 5.0 ml of reference stock solution, add 5.0 ml of a mixture of 10 volumes of methanol R and 100 volumes of glacial acetic acid R then dilute to 25.0 ml with glacial acetic acid R. Thirty min after the addition of the last reagent, measure the absorbance of the test solution and of the reference solution at 420 nm, in comparison with the compensation liquids. Calculate the percentage content m/m of total flavonoids, expressed as rutin, from the expression : A 1 m 2 0:2 p A 2 m 1 A 1 = absorbance of the test solution, A 2 = absorbance of the reference solution, m 1 = mass of the mother tincture sample in the stock solution, in grams, m 2 = mass of rutin sample in the reference stock solution, in grams, p = percentage content of rutin in rutin CRS.